In addition, chemotherapy-induced neuropathy models of neuropathic pain revealed that NLRP3 is upregulated in both oxaliplatin-induced nerve injury (19) and paclitaxel-induced nerve injury (20) models, and inhibition of NLRP3 decreased the mechanical pain-like behaviors in both models. This evidence concerns the gene NLRP3 and neuropathy.